Physician

Thomas J Braza, MD

According to 2025 Medicare claims, Thomas Braza, MD (NPI: 1699883124) practices micrographic dermatologic surgery in the Wilmington, NC market, with the plurality of this provider's patient population coming from Brunswick, NC. This provider's primary affiliated billing organization is BLUEWATER DERMATOLOGY AND SKIN CANCER CENTER PA (NPI: 1245751403; TIN: 821800921) and primary practice location at 28451-9504.

Braza's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,570 traditional Medicare patients, billed 7,715 HCPCS/CPT codes, and received $689,032 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 318 prescription claims across 217 beneficiaries totaling $13,940 in drug costs, led by Fluorouracil (Fluorouracil). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $1,166,650 to $689,032. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $34,867 to $13,940. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$587K$1.2M2015 Medicare payment: $1,166,650 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,174,792 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $875,808 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $509,886 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $524,841 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $651,745 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $686,982 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $707,919 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $649,194 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $689,032 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,88511,600$1,166,650
20161,8559,611$1,174,792
20171,5647,403$875,808
20189405,909$509,886
20191,0366,400$524,841
20201,2807,444$651,745
20211,4908,036$686,982
20221,6317,820$707,919
20231,5687,417$649,194
20241,5707,715$689,032

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$17K$35K2015 Drug cost: $34,867 (USD; Tot_Drug_Cst)2016 Drug cost: $23,692 (USD; Tot_Drug_Cst)2017 Drug cost: $12,797 (USD; Tot_Drug_Cst)2018 Drug cost: $14,889 (USD; Tot_Drug_Cst)2019 Drug cost: $7,842 (USD; Tot_Drug_Cst)2020 Drug cost: $13,128 (USD; Tot_Drug_Cst)2021 Drug cost: $9,880 (USD; Tot_Drug_Cst)2022 Drug cost: $11,743 (USD; Tot_Drug_Cst)2023 Drug cost: $13,568 (USD; Tot_Drug_Cst)2024 Drug cost: $13,940 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015303475$34,867
2016301491$23,692
2017228335$12,797
2018200346$14,889
2019167264$7,842
2020179280$13,128
2021202292$9,880
2022182255$11,743
2023167249$13,568
2024217318$13,940

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks309367$447
11102Biopsy of related skin growth, first growth470582$68
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more9571,034$56
17000Destruction of precancer skin growth, 1 growth736946$39
17003Destruction of precancer skin growth, 2-14 growths5322,769$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FluorouracilFluorouracil1253,717$8,132
KetoconazoleKetoconazole27752$511
CephalexinCephalexin36193$228
ValacyclovirValacyclovir Hcl26117$197
Triamcinolone AcetonideTriamcinolone Acetonide38904$193

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Thomas J. Braza, MD?

Tedicare shows public-source Medicare data for Thomas J. Braza, MD (NPI 1699883124), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas J. Braza, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Thomas J. Braza, MD?

Thomas J. Braza, MD is linked to BLUEWATER DERMATOLOGY AND SKIN CANCER CENTER PA (billing NPI 1245751403) in the available physician profile data.

Does Thomas J. Braza, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.